Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Aktuální cena Merck & Co Inc na trhu je 2 834,67 Kč s 24hodinovým objemem obchodování 12,81B Kč. Tržní kapitalizace aktiva je 6,99T Kč po změně o 0.21% za poslední den.
Tokenizovaný Merck & Co Inc se obchoduje za 2 847,33 Kč, s tokenizovanou tržní kapitalizací 5,89M Kč a 24hodinovým objemem obchodování 7,65M Kč. Tokenizované aktivum se posunulo o -0.00% za posledních 24 hodin.